相关实验视频

Updated: Sep 11, 2025

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

基于高温的多式疗法的疗效取决于守门者蛋白,BID

Sarah Helmueller¹, Xinxin Song², Dong-Hyun Kim^3,4,5,6

¹Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

|August 11, 2025

概括

将阿尔特苏纳酸 (ART) 和复合人体瘤亡因子相关的诱导亡的配体 (rhTRAIL) 与热量相结合,可增强癌细胞亡. 在这种多式疗法中,BID被确定为关键的守门分子,对热引起的亡至关重要.

科学领域:

在瘤学瘤学.
细胞生物学细胞生物学
生物化学生物化学

背景情况:

阿特苏纳酸 (ART) 和复合的人类瘤亡因子相关的诱导亡的配体 (rhTRAIL) 在癌细胞中显示出协同增强亡的作用.
这种组合的目标是细胞内网膜应激和内在/外在细胞死亡途径.
作为结肠癌的二线治疗方法,ART和rhTRAIL显示出前景.

研究的目的:

研究一种多式疗法,结合ART,rhTRAIL和高温 (42°C1小时) 的疗法的疗效.
阐明这种多式疗法的协同效应背后的分子机制.
评估特定的亡相关蛋白在热引起的细胞死亡中的作用.

主要方法:

使用了人类结肠癌HCT116和胰腺腺癌BxPC-3细胞模型.
使用光显微镜和细胞存活检测评估了细胞毒性和协同效应.
通过Westernblotting分析了蛋白质表达和相互作用.

主要成果:

过热显著增强了ART和rhTRAIL的亡和协同效应.
在BID-deficient/mutant和Bax-deficient细胞中,亲亡效应被废除,但不是Bak-deficient细胞.
BID被确定为在高温下诱导亡的关键媒介.

结论:

在基于高温的多式模式癌症治疗中,BID作为关键的守门分子起作用.
这些发现突显了细胞应激路径和热引起的亡之间的复杂相互作用.
这种多模式的方法为提高癌症治疗效率提供了一个有希望的策略.

关键词:

报价要约要约报价要约铁化是铁化的一种.灭症 (apoptosis) 是一种死亡的过程.在这里,我们可以看到BAK BAK BAK BAK.巴克斯巴克斯巴克斯巴克斯交叉语音交叉语音交叉语音交叉语音

更多相关视频

Protocol for Long Duration Whole Body Hyperthermia in Mice

Protocol for Long Duration Whole Body Hyperthermia in Mice

Published on: August 25, 2012

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics

Published on: December 1, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...